KO GENG LIUO: Open Payments
NPI 1841683406 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 62 payments from 11 companies in 2025. Trend: 2023 $457 · 2024 $563 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $346 |
| Teva Pharmaceuticals USA, Inc. | 14 | $262 |
| ABBVIE INC. | 7 | $151 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Neurocrine BioSciences, Inc. | 4 | $88 |
| Alkermes, Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
Products named: REXULTI, AUSTEDO XR, VRAYLAR, UZEDY, FANAPT, INGREZZA, ARISTADA, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
